Want to see TSE:ASEP full AI Analyst Report?

ASEP Medical Holdings Inc (ASEP) Ratios

7 Followers

ASEP Medical Holdings Inc Ratios

TSE:ASEP's free cash flow for Q4 2025 was C$-0.62. For the 2025 fiscal year, TSE:ASEP's free cash flow was decreased by C$ and operating cash flow was C$-7.67. See a summary of the company’s cash flow.

Ratios	TTM	Jun 26	Sep 25	Mar 24	Mar 23
Liquidity Ratios
Current Ratio	―	0.12	―	0.25	6.43
Quick Ratio	―	0.12	―	0.25	6.43
Cash Ratio	―	0.06	―	0.07	4.03
Solvency Ratio	―	-0.96	―	-2.27	-8.47
Operating Cash Flow Ratio	―	-0.42	―	-2.72	-6.84
Short-Term Operating Cash Flow Coverage	―	-175.98	―	-135.63	0.00
Net Current Asset Value	C$ ―	C$ -4.08M	C$ ―	C$ -2.80M	C$ 2.87M
Leverage Ratios
Debt-to-Assets Ratio	―	0.03	―	<0.01	0.00
Debt-to-Equity Ratio	―	0.10	―	<0.01	0.00
Debt-to-Capital Ratio	―	0.09	―	<0.01	0.00
Long-Term Debt-to-Capital Ratio	―	0.09	―	0.00	0.00
Financial Leverage Ratio	―	3.75	―	2.03	1.75
Debt Service Coverage Ratio	―	-57.48	―	-401.38	-5.50K
Interest Coverage Ratio	―	-96.96	―	-28.60K	-6.69K
Debt to Market Cap	―	0.08	―	<0.01	0.00
Interest Debt Per Share	―	0.02	―	<0.01	<0.01
Net Debt to EBITDA	―	-0.04	―	<0.01	0.47
Profitability Margins
Gross Profit Margin	―	-111.23%	―	-538.03%	0.00%
EBIT Margin	―	-761.37%	―	-44608.55%	0.00%
EBITDA Margin	―	-550.14%	―	-38486.19%	0.00%
Operating Profit Margin	―	-761.37%	―	-36524.42%	0.00%
Pretax Profit Margin	―	-2209.72%	―	-44609.81%	0.00%
Net Profit Margin	―	-1459.70%	―	-38918.30%	0.00%
Continuous Operations Profit Margin	―	-2209.72%	―	-44609.81%	0.00%
Net Income Per EBT	―	66.06%	―	87.24%	98.48%
EBT Per EBIT	―	290.23%	―	122.14%	107.42%
Return on Assets (ROA)	―	-56.39%	―	-32.12%	-21.26%
Return on Equity (ROE)	―	-211.23%	―	-65.23%	-37.22%
Return on Capital Employed (ROCE)	―	-40.68%	―	-31.37%	-20.50%
Return on Invested Capital (ROIC)	―	-40.65%	―	-31.34%	-20.19%
Return on Tangible Assets	―	-242.90%	―	-308.93%	-166.93%
Earnings Yield	―	-170.45%	―	-6.45%	-16.01%
Efficiency Ratios
Receivables Turnover	―	31.31	―	0.83	0.00
Payables Turnover	―	0.71	―	0.31	0.29
Inventory Turnover	―	0.00	―	0.00	0.00
Fixed Asset Turnover	―	30.19	―	0.57	0.00
Asset Turnover	―	0.04	―	<0.01	0.00
Working Capital Turnover Ratio	―	-0.13	―	0.02	0.00
Cash Conversion Cycle	―	-503.34	―	-720.43	-1.24K
Days of Sales Outstanding	―	11.66	―	438.95	0.00
Days of Inventory Outstanding	―	0.00	―	0.00	0.00
Days of Payables Outstanding	―	514.99	―	1.16K	1.24K
Operating Cycle	―	11.66	―	438.95	0.00
Cash Flow Ratios
Operating Cash Flow Per Share	―	-0.10	―	-0.04	-0.06
Free Cash Flow Per Share	―	-0.10	―	-0.04	-0.06
CapEx Per Share	―	<0.01	―	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	―	1.00	―	1.00	1.00
Dividend Paid and CapEx Coverage Ratio	―	-339.28K	―	-606.71	-8.31K
Capital Expenditure Coverage Ratio	―	-339.28K	―	-606.71	-8.31K
Operating Cash Flow Coverage Ratio	―	-4.43	―	-135.63	0.00
Operating Cash Flow to Sales Ratio	―	-3.02	―	-128.32	0.00
Free Cash Flow Yield	―	-35.29%	―	-2.13%	-10.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	―	-0.58	―	-15.77	-6.40
Price-to-Sales (P/S) Ratio	―	8.56	―	6.04K	0.00
Price-to-Book (P/B) Ratio	―	1.24	―	10.12	2.32
Price-to-Free Cash Flow (P/FCF) Ratio	―	-2.83	―	-46.96	-9.95
Price-to-Operating Cash Flow Ratio	―	-2.83	―	-47.03	-9.95
Price-to-Earnings Growth (PEG) Ratio	―	0.01	―	-0.53	-0.04
Price-to-Fair Value	―	1.24	―	10.12	2.32
Enterprise Value Multiple	―	-1.60	―	-15.68	-7.41
Enterprise Value	―	2.96M	―	127.54M	33.84M
EV to EBITDA	―	-1.60	―	-15.68	-7.41
EV to Sales	―	8.79	―	6.03K	0.00
EV to Free Cash Flow	―	-2.91	―	-46.94	-9.36
EV to Operating Cash Flow	―	-2.91	―	-47.02	-9.36
Tangible Book Value Per Share	―	-0.23	―	>-0.01	0.05
Shareholders’ Equity Per Share	―	0.23	―	0.20	0.28
Tax and Other Ratios
Effective Tax Rate	―	0.00	―	0.00	0.02
Revenue Per Share	―	0.03	―	<0.01	0.00
Net Income Per Share	―	-0.48	―	-0.13	-0.10
Tax Burden	―	0.66	―	0.87	0.98
Interest Burden	―	2.90	―	1.00	1.00
Research & Development to Revenue	―	0.29	―	32.10	0.00
SG&A to Revenue	―	6.21	―	200.18	0.00
Stock-Based Compensation to Revenue	―	0.00	―	92.34	0.00
Income Quality	―	0.21	―	0.33	0.63

Currency in CAD